ClinicalTrials.Veeva

Menu

Acupuncture for Post COVID-19 Fatigue

G

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Status

Not yet enrolling

Conditions

Post COVID-19 Condition
Acupuncture
Fatigue

Treatments

Device: Sham Acupuncture
Device: Acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT05749757
2023-013-KY-01

Details and patient eligibility

About

The aim of the study is to access the efficacy and safety of acupuncture for post COVID-19 fatigue.

Enrollment

84 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 18 and 75.
  • Confirmed COVID-19 infection in the past four weeks to six months, and a negative RT PCR and/or Antigen-Based Rapid Test at present.
  • A main complaint of fatigue emerged newly following COVID-19 infection.
  • A score of ≥15 on Chalder Fatigue Scale (CFS, score range 0-33).
  • Participating the trial volunteerly and providing written informed consent.

Exclusion criteria

  • Severe anxiety and depression: a score of ≥25 on 17-item Hamilton Rating Scale for Depression (HAMD-17) and/or a score scores >29 on 14-item Hamilton Rating Scale for Anxiety (HAMA-14).
  • Significant cognitive dysfunction or suicidal tendency.
  • Usage of anti-anxiety and/or anti-depression treatments over the last three months.
  • Previously diagnosed hypothyroidism or chronic fatigue syndrome.
  • A complication of serious and poorly controlled underlying diseases.
  • Having symptoms indicating emergency or severe conditions.
  • Concurrent use of other anti-fatigue agents or treatments at present.
  • Impaired walking ability.
  • Pregnant and/or lactating or planning to get pregnant in the next 4 months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

84 participants in 2 patient groups

Acupuncture
Experimental group
Description:
Hwato brand disposable acupuncture needles (size 0.30 × 40 mm) and adhesive pads will be used. Acupoints of Guanyuan, Zhongwan, Tianshu, Zusanli, Taixi, Shangyintang, Taiyang, Hegu, Taichong and Shenmen will be selected. Participants will receive a total of 10-session acupuncture treatment during four weeks, three times a week in the first two weeks and twice a week in the last two weeks.
Treatment:
Device: Acupuncture
Sham Acupuncture
Sham Comparator group
Description:
Hwato brand disposable placebo needles (with the handle identical to the needles in the acupuncture group and the body at a size 0.30 × 25 mm) and adhesive pads will be used. Acupoints of Guanyuan, Zhongwan, Tianshu, Zusanli, Taixi, Shangyintang, Taiyang, Hegu, Taichong and Shenmen will be selected. Participants will receive a total of 10-session sham acupuncture treatment during four weeks, three times a week in the first two weeks and twice a week in the last two weeks.
Treatment:
Device: Sham Acupuncture

Trial contacts and locations

0

Loading...

Central trial contact

Yuanjie Sun

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems